Xuebing Li

中国科学家在线 ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Low Density Lipoprotein

Molecular Docking

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

Nature communications

Journal of medicinal chemistry

Institute of Microbiology Chinese Academy of Sciences

Tottori University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Microbiology Chinese Academy of Sciences

China

Professor (Principal Investigator)

Education History

Tottori University

Japan

PHD

Publications

Pengfei Wang, Babayemi O Oladejo, Chenning Li, Lifeng Fu, Shanshan Zhang, Jianxun Qi, Xun Lv, Xuebing Li
Structure-based design of 5'-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors. RSC advances 11 (16) (2021)
Xun Lv, Pengfei Wang, Chenning Li, Shuihong Cheng, Yuhai Bi, Xuebing Li
Zanamivir-Cholesterol Conjugate: A Long-Acting Neuraminidase Inhibitor with Potent Efficacy against Drug-Resistant Influenza Viruses. Journal of medicinal chemistry 64 (23) (2021)
Lifeng Fu, Fei Ye, Yong Feng, Feng Yu, Qisheng Wang, Yan Wu, Cheng Zhao, Huan Sun, Baoying Huang, Peihua Niu, Hao Song, Yi Shi, Xuebing Li, Wenjie Tan, Jianxun Qi, George Fu Gao
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nature communications 11 (1) (2020)
Xun Lv, Hongzhi Cao, Baixue Lin, Wei Wang, Wande Zhang, Qian Duan, Yong Tao, Xue-Wei Liu, Xuebing Li
Synthesis of Sialic Acids, Their Derivatives, and Analogs by Using a Whole-Cell Catalyst. Chemistry (Weinheim an der Bergstrasse, Germany) 23 (60) (2017)